Skip to content

Effect of Non-invasive Vagal Nerve Stimulation on Selected Outcomes in Central Obesity

Effect of Non-invasive Vagal Nerve Stimulation on Selected Outcomes in Central Obesity

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07341971
Acronym
NVN-CO
Enrollment
60
Registered
2026-01-15
Start date
2026-03-01
Completion date
2026-05-25
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

Trans Cutanous Electric Nerve Stimulation of Auricular Vagus Nerve

Interventions

DEVICETranscutanous Auricular vagus nerve stimulation

Non-invasive Auricular Vagus Stimulation

DEVICESham

Non working device

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
25 Years to 35 Years
Healthy volunteers
No

Inclusion criteria

* Sixty male * Age ranges from 25 to 35 * All them are medically stable with no chronic disease * waist circumference more than 94 * Body Mass Index more than or equal 30

Exclusion criteria

* Individuals with metabolic diseases * Individuals taking cholesterol lowering drugs, Anti-hypertensive drugs, Oral-hypoglycemic drugs * smokers

Design outcomes

Primary

MeasureTime frameDescription
Change in serum Interleukin-6 (IL-6)Baseline and after 4 weeks of interventionserum Interleukin-6 levels will be measured using (ELIZA)

Secondary

MeasureTime frameDescription
Waist CircumferenceBaseline and after 4 weeks of interventionMeasurement of waist circumference in centimeters as an indicator of central adiposity
Body Shape Index (ABSI)Baseline and after 4 weeks of interventionAssessment of body shape using A Body Shape Index calculated from waist circumference, height, and weight.
Depression Anxiety Stress Scale (DASS-21) ScoreBaseline and after 4 weeks of interventionEvaluation of psychological status including depression, anxiety, and stress using the validated Depression Anxiety Stress Scale -21 questionnaire Higher scores indicate greater severity of emotional state The total score represents the sum of all 21 items multiplied by two. Sub scale scores for depression, anxiety and stress will be calculated and analyzed separately.
Pittsburgh Sleep Quality Index (PSQI)Baseline and after 4 weeks of interventionAssessment of sleep quality using the Pittsburgh Sleep Quality Index questionnaire. The total score ranges from 0 to 21 Score greater than 5 indicate poor sleep quality.
Gut Feeling Questionnaire ScoreBaseline and after 4 weeks of interventionEvaluation of gut-related symptoms and gut-brain interaction using a gut feeling questionnaire The total score is calculated by summing all questionnaire items, with higher scores indicating worse gut feelings.

Contacts

CONTACTLamiaa Z Salama, MSc
lamiasalama064@gmail.com01099793264
PRINCIPAL_INVESTIGATORNessreen G Al-Nahas, Professor

Cairo University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026